Ajanta Pharma formed a 'Golden Crossover' as its 50-day EMA crossed above the 200-day EMA, indicating a potential trend reversal. Analyst Mayank Singh Chandel believes the stock may rally if it breaks above recent highs. With strength in the pharma sector and a bullish chart structure, traders may look for fresh entry opportunities on a breakout.